Peter Thompson, a director at Sionna Therapeutics, has executed a sale of shares valued at $4,493. This transaction reflects a movement of equity within the company, although further details regarding the number of shares sold or the reasons for the sale have not been disclosed. The sale is part of the regular trading activities that directors may engage in as part of their financial management.
Related Articles
Don't miss out on breaking stories and in-depth articles.